本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Fennec Pharmaceuticals Inc.

10.96
-0.3400-3.01%
盤後10.960.00000.00%19:30 EDT
成交量:24.99萬
成交額:274.94萬
市值:3.84億
市盈率:-91.33
高:11.51
開:11.30
低:10.85
收:11.30
52周最高:13.25
52周最低:5.65
股本:3,506.72萬
流通股本:1,988.67萬
量比:0.97
換手率:1.26%
股息:- -
股息率:- -
每股收益(TTM):-0.1200
每股收益(LYR):-0.3409
淨資產收益率:-18.58%
總資產收益率:-1.16%
市淨率:9.06
市盈率(LYR):-32.15

資料載入中...

2025/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/04

重要事件披露

Form 8-K - Current report
2025/05/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/10

重要事件披露

Form 8-K - Current report
2025/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/07

重要事件披露

Form 8-K - Current report
2025/02/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities